Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

Baricitinib is effective and safe for treating severe alopecia areata.

Poor air quality increases the risk of atopic dermatitis in Taiwan.

African American adults and non-White children experience more hair loss episodes than White patients with alopecia areata.

Traditional treatment for pediatric alopecia areata is most effective and should be first choice.

Men who went through puberty later had lower sperm counts and altered hormone levels, possibly affecting fertility.

People with ankylosing spondylitis in Taiwan don't have a higher chance of getting alopecia.

Young adults who had liver disease as children often experience significant health problems and frequently need transplants.

Excimer laser therapy may help improve scarring alopecia symptoms and hair appearance.

Finasteride may lower depression risk in younger men with hair loss but increase it in older men with prostate issues.

Combining concentrated growth factor with intense pulsed light is more effective and safer for sensitive skin than using intense pulsed light alone.

Frontal fibrosing alopecia has a higher remission rate than lichen planopilaris.

The treatment effectively improved hair growth and was well tolerated in most men.

Digital care for hair loss significantly improves men's quality of life.

Early treatment with JAK inhibitors leads to better hair regrowth in acute alopecia areata.

Certain skin and family history markers predict vitiligo severity and treatment needs.

Lower postoperative hematocrit levels increase the risk of death within 28 days after coronary artery bypass surgery.

Tofacitinib effectively treats severe alopecia areata, improving hair regrowth and patient satisfaction.

Statins do not help improve alopecia areata.

Statins do not help improve alopecia areata.

Certain blood cell ratios are higher in kids with alopecia areata and might help predict the disease.

Severe COVID-19 increases the risk of hair loss.

5-alpha reductase inhibitors do not increase osteoporosis risk in women with certain hair loss conditions.

Stressful life events may trigger alopecia areata.

People with hidradenitis suppurativa have a higher risk of kidney stones.

Trichoscopy effectively shows early positive effects of minoxidil in male pattern hair loss, improving patient satisfaction.

Bariatric surgery improved quality of life and health in six months, but hair loss was common.

Tofacitinib is more effective than traditional treatments for severe alopecia areata in children.

Anlotinib combined with taxane/capecitabine is more effective than bevacizumab for treating HER-2 negative metastatic breast cancer.

Baseline severity, disease activity, and relapse history are key to predicting response and recurrence in alopecia areata.

Leflunomide may lower alopecia areata risk, while other immunomodulators might increase it.